A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogramming
- PMID: 40102626
- PMCID: PMC11920211
- DOI: 10.1038/s42003-025-07899-y
A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogramming
Abstract
Cell-autonomous barriers to reprogramming somatic cells into induced pluripotent stem cells (iPSCs) remain poorly understood. Using a focused CRISPR-Cas9 screen, we identified Ubiquitin-specific peptidase 22 (USP22) as a key chromatin-based barrier to human iPSC derivation. Suppression of USP22 significantly enhances reprogramming efficiency. Surprisingly, this effect is likely to be independent of USP22's deubiquitinase activity or its association with the SAGA complex, as shown through module-specific knockouts, and genetic rescue experiments. USP22 is not required for iPSC derivation or maintenance. Mechanistically, USP22 loss during reprogramming downregulates fibroblast-specific genes while activating pluripotency-associated genes, including DNMT3L, LIN28A, SOX2, and GDF3. Additionally, USP22 loss enhances reprogramming efficiency under naïve stem cell conditions. These findings reveal an unrecognized role for USP22 in maintaining somatic cell identity and repressing pluripotency genes, highlighting its potential as a target to improve reprogramming efficiency.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Human pluripotent reprogramming with CRISPR activators.Nat Commun. 2018 Jul 6;9(1):2643. doi: 10.1038/s41467-018-05067-x. Nat Commun. 2018. PMID: 29980666 Free PMC article.
-
Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).Stem Cell Res. 2016 Nov;17(3):665-669. doi: 10.1016/j.scr.2016.10.011. Epub 2016 Nov 17. Stem Cell Res. 2016. PMID: 27934604
-
UTF1 Expression is Important for the Generation and Maintenance of Human iPSCs.Stem Cell Rev Rep. 2025 Apr;21(3):859-871. doi: 10.1007/s12015-024-10836-x. Epub 2025 Jan 4. Stem Cell Rev Rep. 2025. PMID: 39754619
-
Cellular trajectories and molecular mechanisms of iPSC reprogramming.Curr Opin Genet Dev. 2018 Oct;52:77-85. doi: 10.1016/j.gde.2018.06.002. Epub 2018 Jun 17. Curr Opin Genet Dev. 2018. PMID: 29925040 Free PMC article. Review.
-
Going up the hill: chromatin-based barriers to epigenetic reprogramming.FEBS J. 2021 Aug;288(16):4798-4811. doi: 10.1111/febs.15628. Epub 2020 Dec 6. FEBS J. 2021. PMID: 33190371 Review.
Cited by
-
Bioinformatic analysis of the role of USP22 expression in hepatocellular carcinoma.Int J Clin Exp Pathol. 2025 Jul 15;18(7):287-301. doi: 10.62347/FXIN5300. eCollection 2025. Int J Clin Exp Pathol. 2025. PMID: 40814554 Free PMC article.
References
-
- Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126, 663–676 (2006). - PubMed
-
- Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131, 861–872 (2007). - PubMed
-
- David, L. & Polo, J. M. Phases of reprogramming. Stem Cell Res.12, 754–761 (2014). - PubMed
-
- Liu, X. et al. Reprogramming roadmap reveals route to human induced trophoblast stem cells. Nature586, 101–107 (2020). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials